Serum homocysteine is not independently associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-21) study
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled tri...
Saved in:
Published in | Atherosclerosis Vol. 249; pp. 59 - 64 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
01.06.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9150 1879-1484 1879-1484 |
DOI | 10.1016/j.atherosclerosis.2016.03.031 |
Cover
Abstract | Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures.
Our analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3-C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression.
In unadjusted analysis, levels of LDL-C (p < 0.001), non-HDL-C (p < 0.001) and HDL-C (p < 0.001) were 7–10% lower whereas levels of TG (p < 0.001), VLDL-C (p = 0.016) and RLP-C (p < 0.001) were 2–6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated (p-value range: 0.101–0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN.
Although high levels of tHcy were associated with 2–6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile.
[Display omitted]
•We examine the association between homocysteine (tHcy) and an extended lipid panel.•We compare lipid distributions between the highest and lowest quartile of tHcy.•We adjust for age, sex, HbA1c, insulin, creatinine, and blood urea nitrogen.•After adjustment, higher tHcy was not associated with any lipid differences. |
---|---|
AbstractList | Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures.
Our analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3-C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression.
In unadjusted analysis, levels of LDL-C (p < 0.001), non-HDL-C (p < 0.001) and HDL-C (p < 0.001) were 7–10% lower whereas levels of TG (p < 0.001), VLDL-C (p = 0.016) and RLP-C (p < 0.001) were 2–6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated (p-value range: 0.101–0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN.
Although high levels of tHcy were associated with 2–6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile.
[Display omitted]
•We examine the association between homocysteine (tHcy) and an extended lipid panel.•We compare lipid distributions between the highest and lowest quartile of tHcy.•We adjust for age, sex, HbA1c, insulin, creatinine, and blood urea nitrogen.•After adjustment, higher tHcy was not associated with any lipid differences. Abstract Background and aims Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures. Methods Our analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3 -C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression. Results In unadjusted analysis, levels of LDL-C ( p < 0.001), non-HDL-C ( p < 0.001) and HDL-C ( p < 0.001) were 7–10% lower whereas levels of TG ( p < 0.001), VLDL-C ( p = 0.016) and RLP-C ( p < 0.001) were 2–6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated ( p -value range: 0.101–0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN. Conclusions Although high levels of tHcy were associated with 2–6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile. Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures. Our analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3-C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression. In unadjusted analysis, levels of LDL-C (p < 0.001), non-HDL-C (p < 0.001) and HDL-C (p < 0.001) were 7-10% lower whereas levels of TG (p < 0.001), VLDL-C (p = 0.016) and RLP-C (p < 0.001) were 2-6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated (p-value range: 0.101-0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN. Although high levels of tHcy were associated with 2-6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile. Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures.BACKGROUND AND AIMSHyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total homocysteine (tHcy) has been shown to decrease strokes, there is no evidence for an effect on myocardial infarctions in randomized controlled trials. This study aims to examine the relationship between tHcy and several lipid measures.Our analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3-C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression.METHODSOur analyses included 18,297 U.S. adults from the Very Large Database of Lipids who had an extended lipid panel including direct measurement of triglycerides (TG), and the cholesterol concentration of low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), non-HDL-C, very low-density lipoprotein (VLDL-C), and remnant-lipoprotein cholesterol (RLP-C: IDL-C + VLDL3-C). Additional measurements were tHcy, hemoglobin A1c (HbA1c), insulin, creatinine, and blood urea nitrogen (BUN). Subjects were categorized into tHcy quartiles. Linear regression models were performed using lipids and tHcy as dependent and independent variables respectively, and further adjusted with age, sex, HbA1c, insulin, creatinine, and BUN levels in multivariable regression.In unadjusted analysis, levels of LDL-C (p < 0.001), non-HDL-C (p < 0.001) and HDL-C (p < 0.001) were 7-10% lower whereas levels of TG (p < 0.001), VLDL-C (p = 0.016) and RLP-C (p < 0.001) were 2-6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated (p-value range: 0.101-0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN.RESULTSIn unadjusted analysis, levels of LDL-C (p < 0.001), non-HDL-C (p < 0.001) and HDL-C (p < 0.001) were 7-10% lower whereas levels of TG (p < 0.001), VLDL-C (p = 0.016) and RLP-C (p < 0.001) were 2-6% higher in the highest tHcy quartile. These associations between tHcy levels and lipids were eliminated (p-value range: 0.101-0.750) when controlling for age, sex, HbA1c, insulin, creatinine, and BUN.Although high levels of tHcy were associated with 2-6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile.CONCLUSIONSAlthough high levels of tHcy were associated with 2-6% higher TG-rich lipoproteins in unadjusted analysis, after adjustment for confounders our findings do not support the hypothesis that hyperhomocysteinemia is associated with an atherogenic lipid profile. |
Author | Kulkarni, Krishnaji Lupton, Joshua R. Martin, Seth S. Quispe, Renato Jones, Steven R. |
Author_xml | – sequence: 1 givenname: Joshua R. surname: Lupton fullname: Lupton, Joshua R. organization: Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD, USA – sequence: 2 givenname: Renato surname: Quispe fullname: Quispe, Renato organization: Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD, USA – sequence: 3 givenname: Krishnaji surname: Kulkarni fullname: Kulkarni, Krishnaji organization: Atherotech Diagnostics Laboratory, Birmingham, AL, USA – sequence: 4 givenname: Seth S. surname: Martin fullname: Martin, Seth S. organization: Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD, USA – sequence: 5 givenname: Steven R. surname: Jones fullname: Jones, Steven R. email: sjones64@jhmi.edu organization: Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27065242$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkt9qFDEUxoNU7Lb6CpIboV7MmszfjKAg21qFAS9ai3chmznpZs0k2yRjmSfoa5th25sFoUI4gfCdX8453zlBR9ZZQOgdJUtKaP1huxRxA94FaeaowzJPz0tSpENfoAVlTZvRkpVHaEFITrOWVuQYnYSwJYSUDWWv0HHekLrKy3yBHq7AjwPeuMHJKUTQFrAO2LqIte1hBynYaCYsQnBSiwg9vtdxg4XF-0JuwWqJjd7pHu-8U9rAR3y9AXwDfsKd8LeAz0UUaxEAO4W7WRnw2U133mU5fY9DHPvpNXqphAnw5vE-RT-_XlyvvmXdj8vvqy9dJitSx0zUrSyhqFqZelOtqupKMgGKiKpROZO0KRWwkpG-lpSBEGxdKjV3WzewBlKcorM9N5V6N0KIfNBBgjHCghsDp01Li5wyUifp20fpuB6g5zuvB-En_jS8JFjtBTIZETwoLnUUUTsbvdCGU8Jny_iWH1jGZ8s4KdKhifLpgPL00XPzL_f5kMb2R4PnQWqwEnrtQUbeO_1s0ucDkjQ6mSvMb5ggbN3obfKGUx5yTvjVvF7zdtG6IJTUvxLg4t-A_yjkL0ot7I4 |
CitedBy_id | crossref_primary_10_1016_j_arr_2018_10_010 crossref_primary_10_1016_j_exger_2017_01_012 crossref_primary_10_1186_s12944_017_0441_6 crossref_primary_10_1016_j_ejim_2024_10_014 crossref_primary_10_1080_09637486_2018_1547688 crossref_primary_10_3389_fcvm_2022_898305 crossref_primary_10_1097_MD_0000000000032464 crossref_primary_10_1002_jcla_24563 crossref_primary_10_1097_MOL_0000000000000429 crossref_primary_10_1186_s12944_023_01793_4 crossref_primary_10_1021_acsomega_4c05204 crossref_primary_10_1007_s11357_019_00129_4 |
Cites_doi | 10.1631/jzus.B1400183 10.1093/ajh/hpu248 10.4103/2230-8210.126532 10.1046/j.1365-2796.2003.01184.x 10.1001/jama.1995.03530130055028 10.1371/journal.pone.0113148 10.1016/j.numecd.2004.05.003 10.1111/j.1742-1241.2012.02929.x 10.1023/A:1019559328424 10.1016/j.jjcc.2012.11.009 10.1371/journal.pmed.0020135 10.1182/blood-2011-01-333310 10.1186/1743-7075-2-13 10.1002/clc.22214 10.1152/ajpendo.00518.2004 10.1186/1479-5876-7-97 10.1016/S0005-2760(98)00086-1 10.1161/01.RES.0000242559.42077.22 10.1016/j.diabres.2012.05.027 10.1161/01.ATV.20.7.1704 10.1001/jama.2011.1834 10.1016/S0140-6736(13)60595-4 10.1136/bmj.c6273 10.1016/j.febslet.2009.03.038 10.1203/01.pdr.0000246099.39469.18 10.1212/WNL.0b013e3182a823cc 10.1001/jama.2015.2274 10.1016/j.cll.2006.07.004 10.2174/1875038901306010001 10.1172/JCI11596 10.1016/j.atherosclerosis.2014.06.021 10.5551/jat.2196 10.1016/j.atherosclerosis.2010.11.031 10.1016/j.clnu.2011.01.003 10.1016/j.metabol.2007.05.010 10.3346/jkms.2014.29.6.788 10.1056/NEJMoa060900 10.1007/BF02913076 10.1016/j.jacc.2011.05.028 10.1152/ajpheart.00548.2005 10.1016/S0140-6736(09)60697-8 10.1016/S0009-9120(01)00187-4 10.1186/1476-511X-10-137 10.1161/01.STR.0000185929.38534.f3 10.1016/j.clinbiochem.2007.07.014 10.3945/jn.108.090704 10.1161/01.ATV.0000254151.00086.26 10.1016/j.jdiacomp.2003.12.003 10.1016/S1474-4422(07)70219-3 10.1016/S1047-2797(03)00242-4 |
ContentType | Journal Article |
Copyright | 2016 Elsevier Ireland Ltd Elsevier Ireland Ltd Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.atherosclerosis.2016.03.031 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-1484 |
EndPage | 64 |
ExternalDocumentID | 27065242 10_1016_j_atherosclerosis_2016_03_031 S002191501630106X 1_s2_0_S002191501630106X |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEB HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B M27 M41 MO0 N9A O-L O9- OAUVE OA~ OK1 OL0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW NCXOZ RIG 0SF AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c506t-a69c4e359c002f9f565c8aef0a57f28c174fe8480d6c18eaa8b4ff706567ebe03 |
IEDL.DBID | AIKHN |
ISSN | 0021-9150 1879-1484 |
IngestDate | Fri Sep 05 09:10:23 EDT 2025 Wed Feb 19 02:40:28 EST 2025 Tue Jul 01 04:08:21 EDT 2025 Thu Apr 24 23:07:00 EDT 2025 Fri Feb 23 02:24:03 EST 2024 Tue Feb 25 19:57:37 EST 2025 Tue Aug 26 16:36:45 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Lipoprotein Homocysteine Kidney function Glycemic status Lipid Atherosclerosis |
Language | English |
License | Copyright © 2016 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c506t-a69c4e359c002f9f565c8aef0a57f28c174fe8480d6c18eaa8b4ff706567ebe03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 27065242 |
PQID | 1791321806 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1791321806 pubmed_primary_27065242 crossref_citationtrail_10_1016_j_atherosclerosis_2016_03_031 crossref_primary_10_1016_j_atherosclerosis_2016_03_031 elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2016_03_031 elsevier_clinicalkeyesjournals_1_s2_0_S002191501630106X elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2016_03_031 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-06-01 |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Atherosclerosis |
PublicationTitleAlternate | Atherosclerosis |
PublicationYear | 2016 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | Gueant-Rodriguez, Spada, Moreno-Garcia (bib19) 2011; 214 Tyagi, Sedoris, Steed, Ovechkin, Moshal, Tyagi (bib5) 2005; 289 O, Lynn, Chung, Siow, Man, Choy (bib12) 1998; 1393 Spence, Stampfer (bib31) 2011; 306 Spence (bib30) 2007; 6 Xiao, Zhang, Lv (bib17) 2011; 10 Ray, Seshasai, Wijesuriya (bib38) 2009; 373 Duncan, Li, Zhou (bib52) 2005; 2 Huo, Qin, Wang (bib24) 2012; 66 Obeid, Herrmann (bib9) 2009; 583 Mahalle, Garg, Naik, Kulkarni (bib15) 2014; 18 Lonn, Yusuf, Arnold (bib25) 2006; 354 Pang, Liu, Zhao (bib6) 2014; 236 Lakhan, Kirchgessner, Hofer (bib53) 2009; 7 Liao, Tan, Hui (bib13) 2006; 99 Galan, Kesse-Guyot, Czernichow (bib27) 2010; 341 Iqbal, Ishaq, Kazmi (bib54) 2005; 15 Catena, Colussi, Nait, Capobianco, Sechi (bib32) 2014; 28 Kulkarni (bib46) 2006; 26 Cheng, Jiang, Kruger (bib7) 2011; 118 Elshorbagy, Oulhaj, Konstantinova (bib39) 2007; 40 Yadav, Bhagwat, Rathod (bib49) 2006; 21 Werstuck, Lentz, Dayal (bib11) 2001; 107 Peng, Man, Xu, Fan (bib3) 2015; 16 Holven, Aukrust, Retterstol (bib18) 2008; 138 Passaro, Calzoni, Volpato (bib36) 2003; 254 Real, Martinez-Hervas, Garcia-Garcia (bib20) 2009; 16 Olthof, van Vliet, Verhoef, Zock, Katan (bib50) 2005; 2 Martin, Blaha, Toth (bib45) 2013; 36 Mahalle, Kulkarni, Garg, Naik (bib41) 2013; 61 Veeranna, Zalawadiya, Niraj (bib33) 2011; 58 Woo, Siow, Pierce (bib10) 2005; 288 Ziakka, Rammos, Kountouris (bib43) 2001; 33 Wang, Ye, Cao (bib37) 2014; 9 de Luis, Fernandez, Arranz, Aller, Izaola, Romero (bib16) 2005; 19 Ahmed, Elshazly, Martin, Blaha, Kulkarni, Jones (bib47) 2013; 6 Qujeq, Omran, Hosini (bib14) 2001; 34 Ji, Tan, Xu (bib23) 2013; 81 Mudd, Finkelstein, Refsum (bib1) 2000; 20 Marti-Carvajal, Sola, Lathyris (bib21) 2015; 1 Gillum (bib48) 2004; 14 Sudchada, Saokaew, Sridetch, Incampa, Jaiyen, Khaithong (bib51) 2012; 98 Colgan, Austin (bib4) 2007; 27 Spence, Bang, Chambless, Stampfer (bib28) 2005; 36 Huo, Li, Qin (bib29) 2015; 313 Gansevoort, Correa-Rotter, Hemmelgarn (bib40) 2013; 382 Refsum, Smith (bib26) 2006; 355 Choi, Kim, Song (bib35) 2014; 29 Luo, Xiao, Yang (bib8) 2014; 11 Chen, Cui, Wu, Xie (bib34) 2013; 6 Anan, Masaki, Umeno (bib42) 2007; 56 Huemer, Vonblon, Fodinger (bib44) 2006; 60 Huang, Chen, Yang, Yang, Wahlqvist, Li (bib22) 2012; 31 Boushey, Beresford, Omenn, Motulsky (bib2) 1995; 274 Veeranna (10.1016/j.atherosclerosis.2016.03.031_bib33) 2011; 58 Ji (10.1016/j.atherosclerosis.2016.03.031_bib23) 2013; 81 Gueant-Rodriguez (10.1016/j.atherosclerosis.2016.03.031_bib19) 2011; 214 Lakhan (10.1016/j.atherosclerosis.2016.03.031_bib53) 2009; 7 Spence (10.1016/j.atherosclerosis.2016.03.031_bib31) 2011; 306 Tyagi (10.1016/j.atherosclerosis.2016.03.031_bib5) 2005; 289 Pang (10.1016/j.atherosclerosis.2016.03.031_bib6) 2014; 236 Galan (10.1016/j.atherosclerosis.2016.03.031_bib27) 2010; 341 Werstuck (10.1016/j.atherosclerosis.2016.03.031_bib11) 2001; 107 Xiao (10.1016/j.atherosclerosis.2016.03.031_bib17) 2011; 10 Huo (10.1016/j.atherosclerosis.2016.03.031_bib29) 2015; 313 Real (10.1016/j.atherosclerosis.2016.03.031_bib20) 2009; 16 de Luis (10.1016/j.atherosclerosis.2016.03.031_bib16) 2005; 19 Wang (10.1016/j.atherosclerosis.2016.03.031_bib37) 2014; 9 Anan (10.1016/j.atherosclerosis.2016.03.031_bib42) 2007; 56 Yadav (10.1016/j.atherosclerosis.2016.03.031_bib49) 2006; 21 Kulkarni (10.1016/j.atherosclerosis.2016.03.031_bib46) 2006; 26 Cheng (10.1016/j.atherosclerosis.2016.03.031_bib7) 2011; 118 Boushey (10.1016/j.atherosclerosis.2016.03.031_bib2) 1995; 274 Gillum (10.1016/j.atherosclerosis.2016.03.031_bib48) 2004; 14 Ahmed (10.1016/j.atherosclerosis.2016.03.031_bib47) 2013; 6 Spence (10.1016/j.atherosclerosis.2016.03.031_bib28) 2005; 36 Choi (10.1016/j.atherosclerosis.2016.03.031_bib35) 2014; 29 Huemer (10.1016/j.atherosclerosis.2016.03.031_bib44) 2006; 60 Mahalle (10.1016/j.atherosclerosis.2016.03.031_bib41) 2013; 61 Martin (10.1016/j.atherosclerosis.2016.03.031_bib45) 2013; 36 Huo (10.1016/j.atherosclerosis.2016.03.031_bib24) 2012; 66 Peng (10.1016/j.atherosclerosis.2016.03.031_bib3) 2015; 16 Marti-Carvajal (10.1016/j.atherosclerosis.2016.03.031_bib21) 2015; 1 Passaro (10.1016/j.atherosclerosis.2016.03.031_bib36) 2003; 254 Ray (10.1016/j.atherosclerosis.2016.03.031_bib38) 2009; 373 Huang (10.1016/j.atherosclerosis.2016.03.031_bib22) 2012; 31 Obeid (10.1016/j.atherosclerosis.2016.03.031_bib9) 2009; 583 Mudd (10.1016/j.atherosclerosis.2016.03.031_bib1) 2000; 20 Qujeq (10.1016/j.atherosclerosis.2016.03.031_bib14) 2001; 34 Mahalle (10.1016/j.atherosclerosis.2016.03.031_bib15) 2014; 18 Woo (10.1016/j.atherosclerosis.2016.03.031_bib10) 2005; 288 O (10.1016/j.atherosclerosis.2016.03.031_bib12) 1998; 1393 Ziakka (10.1016/j.atherosclerosis.2016.03.031_bib43) 2001; 33 Gansevoort (10.1016/j.atherosclerosis.2016.03.031_bib40) 2013; 382 Luo (10.1016/j.atherosclerosis.2016.03.031_bib8) 2014; 11 Elshorbagy (10.1016/j.atherosclerosis.2016.03.031_bib39) 2007; 40 Refsum (10.1016/j.atherosclerosis.2016.03.031_bib26) 2006; 355 Iqbal (10.1016/j.atherosclerosis.2016.03.031_bib54) 2005; 15 Duncan (10.1016/j.atherosclerosis.2016.03.031_bib52) 2005; 2 Olthof (10.1016/j.atherosclerosis.2016.03.031_bib50) 2005; 2 Sudchada (10.1016/j.atherosclerosis.2016.03.031_bib51) 2012; 98 Catena (10.1016/j.atherosclerosis.2016.03.031_bib32) 2014; 28 Liao (10.1016/j.atherosclerosis.2016.03.031_bib13) 2006; 99 Colgan (10.1016/j.atherosclerosis.2016.03.031_bib4) 2007; 27 Lonn (10.1016/j.atherosclerosis.2016.03.031_bib25) 2006; 354 Spence (10.1016/j.atherosclerosis.2016.03.031_bib30) 2007; 6 Chen (10.1016/j.atherosclerosis.2016.03.031_bib34) 2013; 6 Holven (10.1016/j.atherosclerosis.2016.03.031_bib18) 2008; 138 |
References_xml | – volume: 10 year: 2011 ident: bib17 article-title: Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects publication-title: Lipids Health Dis. – volume: 118 start-page: 1998 year: 2011 end-page: 2006 ident: bib7 article-title: Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice publication-title: Blood – volume: 236 start-page: 73 year: 2014 end-page: 81 ident: bib6 article-title: Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-kappaB signal pathway in rat vascular smooth muscle cells publication-title: Atherosclerosis – volume: 27 start-page: 8 year: 2007 end-page: 11 ident: bib4 article-title: Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within! publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 341 start-page: c6273 year: 2010 ident: bib27 article-title: Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial publication-title: BMJ – volume: 107 start-page: 1263 year: 2001 end-page: 1273 ident: bib11 article-title: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways publication-title: J. Clin. Investig. – volume: 61 start-page: 289 year: 2013 end-page: 294 ident: bib41 article-title: Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in indian subjects with coronary artery disease publication-title: J. Cardiol. – volume: 99 start-page: 598 year: 2006 end-page: 606 ident: bib13 article-title: Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance publication-title: Circ. Res. – volume: 1393 start-page: 317 year: 1998 end-page: 324 ident: bib12 article-title: Homocysteine stimulates the production and secretion of cholesterol in hepatic cells publication-title: Biochim. Biophys. Acta – volume: 6 start-page: 779 year: 2013 end-page: 784 ident: bib34 article-title: Relationship of serum homocysteine level with nutritional status and HbA1c level in elderly inpatients publication-title: Int. J. Clin. Exp. Med. – volume: 81 start-page: 1298 year: 2013 end-page: 1307 ident: bib23 article-title: Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis publication-title: Neurology – volume: 6 start-page: 830 year: 2007 end-page: 838 ident: bib30 article-title: Homocysteine-lowering therapy: a role in stroke prevention? publication-title: Lancet Neurol. – volume: 98 start-page: 151 year: 2012 end-page: 158 ident: bib51 article-title: Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis publication-title: Diabetes Res. Clin. Pract. – volume: 20 start-page: 1704 year: 2000 end-page: 1706 ident: bib1 article-title: Homocysteine and its disulfide derivatives: a suggested consensus terminology publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 289 start-page: H2649 year: 2005 end-page: H2656 ident: bib5 article-title: Mechanisms of homocysteine-induced oxidative stress publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 40 start-page: 1209 year: 2007 end-page: 1218 ident: bib39 article-title: Plasma creatinine as a determinant of plasma total homocysteine concentrations in the hordaland homocysteine study: use of statistical modeling to determine reference limits publication-title: Clin. Biochem. – volume: 9 start-page: e113148 year: 2014 ident: bib37 article-title: The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome publication-title: PLoS One – volume: 2 start-page: e135 year: 2005 ident: bib50 article-title: Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans publication-title: PLoS Med. – volume: 7 year: 2009 ident: bib53 article-title: Inflammatory mechanisms in ischemic stroke: therapeutic approaches publication-title: J. Transl. Med. – volume: 583 start-page: 1215 year: 2009 end-page: 1225 ident: bib9 article-title: Homocysteine and lipids: S-adenosyl methionine as a key intermediate publication-title: FEBS Lett. – volume: 138 start-page: 2070 year: 2008 end-page: 2075 ident: bib18 article-title: The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects publication-title: J. Nutr. – volume: 16 start-page: 78 year: 2015 end-page: 86 ident: bib3 article-title: Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies publication-title: J. Zhejiang Univ. Sci. B – volume: 373 start-page: 1765 year: 2009 end-page: 1772 ident: bib38 article-title: Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials publication-title: Lancet – volume: 254 start-page: 264 year: 2003 end-page: 271 ident: bib36 article-title: Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up publication-title: J. Intern Med. – volume: 34 start-page: 97 year: 2001 end-page: 101 ident: bib14 article-title: Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction publication-title: Clin. Biochem. – volume: 214 start-page: 480 year: 2011 end-page: 485 ident: bib19 article-title: Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population publication-title: Atherosclerosis – volume: 26 start-page: 787 year: 2006 end-page: 802 ident: bib46 article-title: Cholesterol profile measurement by vertical auto profile method publication-title: Clin. Lab. Med. – volume: 18 start-page: 48 year: 2014 end-page: 55 ident: bib15 article-title: Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease publication-title: Indian J. Endocrinol. Metab. – volume: 66 start-page: 544 year: 2012 end-page: 551 ident: bib24 article-title: Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis publication-title: Int. J. Clin. Pract. – volume: 16 start-page: 815 year: 2009 end-page: 820 ident: bib20 article-title: Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia publication-title: J. Atheroscler. Thromb. – volume: 33 start-page: 559 year: 2001 end-page: 562 ident: bib43 article-title: The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis publication-title: Int. Urol. Nephrol. – volume: 36 start-page: 2404 year: 2005 end-page: 2409 ident: bib28 article-title: Vitamin intervention for stroke prevention trial: an efficacy analysis publication-title: Stroke – volume: 6 start-page: 1 year: 2013 end-page: 5 ident: bib47 article-title: Ratio of dense to buoyant LDL subclass is associated with LDL density phenotype (VLDL-5) publication-title: Open Chem. Biomed. Methods J. – volume: 274 start-page: 1049 year: 1995 end-page: 1057 ident: bib2 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. probable benefits of increasing folic acid intakes publication-title: JAMA – volume: 2 start-page: 13 year: 2005 ident: bib52 article-title: Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. results from the 1999-2002 national health and nutrition examination survey publication-title: Nutr. Metab. Lond. – volume: 288 start-page: E1002 year: 2005 end-page: E1010 ident: bib10 article-title: Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors publication-title: Am. J. Physiol. Endocrinol. Metab. – volume: 306 start-page: 2610 year: 2011 end-page: 2611 ident: bib31 article-title: Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses publication-title: JAMA – volume: 354 start-page: 1567 year: 2006 end-page: 1577 ident: bib25 article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease publication-title: N. Engl. J. Med. – volume: 1 start-page: CD006612 year: 2015 ident: bib21 article-title: Homocysteine-lowering interventions for preventing cardiovascular events publication-title: Cochrane Database Syst. Rev. – volume: 11 year: 2014 ident: bib8 article-title: Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes publication-title: Nutr. Metab. Lond. – volume: 36 start-page: 641 year: 2013 end-page: 648 ident: bib45 article-title: Very large database of lipids: rationale and design publication-title: Clin. Cardiol. – volume: 31 start-page: 448 year: 2012 end-page: 454 ident: bib22 article-title: Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality publication-title: Clin. Nutr. – volume: 355 start-page: 207 year: 2006 ident: bib26 article-title: Homocysteine, B vitamins, and cardiovascular disease publication-title: N. Engl. J. Med. – volume: 28 start-page: 943 year: 2014 end-page: 950 ident: bib32 article-title: Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients publication-title: Am. J. Hypertens. – volume: 56 start-page: 1390 year: 2007 end-page: 1395 ident: bib42 article-title: Correlations between homocysteine levels and atherosclerosis in japanese type 2 diabetic patients publication-title: Metabolism – volume: 14 start-page: 229 year: 2004 end-page: 233 ident: bib48 article-title: Distribution of total serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: the third national health and nutrition examination survey publication-title: Ann. Epidemiol. – volume: 382 start-page: 339 year: 2013 end-page: 352 ident: bib40 article-title: Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention publication-title: Lancet – volume: 58 start-page: 1025 year: 2011 end-page: 1033 ident: bib33 article-title: Homocysteine and reclassification of cardiovascular disease risk publication-title: J. Am. Coll. Cardiol. – volume: 29 start-page: 788 year: 2014 end-page: 792 ident: bib35 article-title: Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients publication-title: J. Korean Med. Sci. – volume: 15 start-page: 100 year: 2005 end-page: 108 ident: bib54 article-title: Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a pakistani population of patients with acute myocardial infarction publication-title: Nutr. Metab. Cardiovasc. Dis. – volume: 313 start-page: 1325 year: 2015 end-page: 1335 ident: bib29 article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in china: the CSPPT randomized clinical trial publication-title: JAMA – volume: 21 start-page: 106 year: 2006 end-page: 110 ident: bib49 article-title: Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease publication-title: Indian J. Clin. Biochem. – volume: 60 start-page: 764 year: 2006 end-page: 769 ident: bib44 article-title: Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents publication-title: Pediatr. Res. – volume: 19 start-page: 42 year: 2005 end-page: 46 ident: bib16 article-title: Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 publication-title: J. Diabetes Complicat. – volume: 16 start-page: 78 issue: 1 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.031_bib3 article-title: Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies publication-title: J. Zhejiang Univ. Sci. B doi: 10.1631/jzus.B1400183 – volume: 28 start-page: 943 issue: 7 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib32 article-title: Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients publication-title: Am. J. Hypertens. doi: 10.1093/ajh/hpu248 – volume: 18 start-page: 48 issue: 1 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib15 article-title: Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease publication-title: Indian J. Endocrinol. Metab. doi: 10.4103/2230-8210.126532 – volume: 254 start-page: 264 issue: 3 year: 2003 ident: 10.1016/j.atherosclerosis.2016.03.031_bib36 article-title: Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up publication-title: J. Intern Med. doi: 10.1046/j.1365-2796.2003.01184.x – volume: 274 start-page: 1049 issue: 13 year: 1995 ident: 10.1016/j.atherosclerosis.2016.03.031_bib2 article-title: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. probable benefits of increasing folic acid intakes publication-title: JAMA doi: 10.1001/jama.1995.03530130055028 – volume: 9 start-page: e113148 issue: 11 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib37 article-title: The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome publication-title: PLoS One doi: 10.1371/journal.pone.0113148 – volume: 15 start-page: 100 issue: 2 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib54 article-title: Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a pakistani population of patients with acute myocardial infarction publication-title: Nutr. Metab. Cardiovasc. Dis. doi: 10.1016/j.numecd.2004.05.003 – volume: 66 start-page: 544 issue: 6 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.031_bib24 article-title: Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis publication-title: Int. J. Clin. Pract. doi: 10.1111/j.1742-1241.2012.02929.x – volume: 33 start-page: 559 issue: 3 year: 2001 ident: 10.1016/j.atherosclerosis.2016.03.031_bib43 article-title: The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis publication-title: Int. Urol. Nephrol. doi: 10.1023/A:1019559328424 – volume: 61 start-page: 289 issue: 4 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib41 article-title: Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in indian subjects with coronary artery disease publication-title: J. Cardiol. doi: 10.1016/j.jjcc.2012.11.009 – volume: 2 start-page: e135 issue: 5 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib50 article-title: Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans publication-title: PLoS Med. doi: 10.1371/journal.pmed.0020135 – volume: 118 start-page: 1998 issue: 7 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.031_bib7 article-title: Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice publication-title: Blood doi: 10.1182/blood-2011-01-333310 – volume: 2 start-page: 13 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib52 article-title: Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. results from the 1999-2002 national health and nutrition examination survey publication-title: Nutr. Metab. Lond. doi: 10.1186/1743-7075-2-13 – volume: 36 start-page: 641 issue: 11 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib45 article-title: Very large database of lipids: rationale and design publication-title: Clin. Cardiol. doi: 10.1002/clc.22214 – volume: 288 start-page: E1002 issue: 5 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib10 article-title: Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00518.2004 – volume: 7 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.031_bib53 article-title: Inflammatory mechanisms in ischemic stroke: therapeutic approaches publication-title: J. Transl. Med. doi: 10.1186/1479-5876-7-97 – volume: 1393 start-page: 317 issue: 2–3 year: 1998 ident: 10.1016/j.atherosclerosis.2016.03.031_bib12 article-title: Homocysteine stimulates the production and secretion of cholesterol in hepatic cells publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2760(98)00086-1 – volume: 99 start-page: 598 issue: 6 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib13 article-title: Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance publication-title: Circ. Res. doi: 10.1161/01.RES.0000242559.42077.22 – volume: 1 start-page: CD006612 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.031_bib21 article-title: Homocysteine-lowering interventions for preventing cardiovascular events publication-title: Cochrane Database Syst. Rev. – volume: 355 start-page: 207 issue: 2 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib26 article-title: Homocysteine, B vitamins, and cardiovascular disease publication-title: N. Engl. J. Med. – volume: 98 start-page: 151 issue: 1 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.031_bib51 article-title: Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2012.05.027 – volume: 20 start-page: 1704 issue: 7 year: 2000 ident: 10.1016/j.atherosclerosis.2016.03.031_bib1 article-title: Homocysteine and its disulfide derivatives: a suggested consensus terminology publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.20.7.1704 – volume: 306 start-page: 2610 issue: 23 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.031_bib31 article-title: Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses publication-title: JAMA doi: 10.1001/jama.2011.1834 – volume: 382 start-page: 339 issue: 9889 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib40 article-title: Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention publication-title: Lancet doi: 10.1016/S0140-6736(13)60595-4 – volume: 341 start-page: c6273 year: 2010 ident: 10.1016/j.atherosclerosis.2016.03.031_bib27 article-title: Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial publication-title: BMJ doi: 10.1136/bmj.c6273 – volume: 583 start-page: 1215 issue: 8 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.031_bib9 article-title: Homocysteine and lipids: S-adenosyl methionine as a key intermediate publication-title: FEBS Lett. doi: 10.1016/j.febslet.2009.03.038 – volume: 60 start-page: 764 issue: 6 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib44 article-title: Total homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and body mass index in healthy children and adolescents publication-title: Pediatr. Res. doi: 10.1203/01.pdr.0000246099.39469.18 – volume: 81 start-page: 1298 issue: 15 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib23 article-title: Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis publication-title: Neurology doi: 10.1212/WNL.0b013e3182a823cc – volume: 313 start-page: 1325 issue: 13 year: 2015 ident: 10.1016/j.atherosclerosis.2016.03.031_bib29 article-title: Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in china: the CSPPT randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2015.2274 – volume: 26 start-page: 787 issue: 4 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib46 article-title: Cholesterol profile measurement by vertical auto profile method publication-title: Clin. Lab. Med. doi: 10.1016/j.cll.2006.07.004 – volume: 6 start-page: 1 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib47 article-title: Ratio of dense to buoyant LDL subclass is associated with LDL density phenotype (VLDL-5) publication-title: Open Chem. Biomed. Methods J. doi: 10.2174/1875038901306010001 – volume: 107 start-page: 1263 issue: 10 year: 2001 ident: 10.1016/j.atherosclerosis.2016.03.031_bib11 article-title: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways publication-title: J. Clin. Investig. doi: 10.1172/JCI11596 – volume: 236 start-page: 73 issue: 1 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib6 article-title: Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-kappaB signal pathway in rat vascular smooth muscle cells publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2014.06.021 – volume: 16 start-page: 815 issue: 6 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.031_bib20 article-title: Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia publication-title: J. Atheroscler. Thromb. doi: 10.5551/jat.2196 – volume: 214 start-page: 480 issue: 2 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.031_bib19 article-title: Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2010.11.031 – volume: 31 start-page: 448 issue: 4 year: 2012 ident: 10.1016/j.atherosclerosis.2016.03.031_bib22 article-title: Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2011.01.003 – volume: 56 start-page: 1390 issue: 10 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.031_bib42 article-title: Correlations between homocysteine levels and atherosclerosis in japanese type 2 diabetic patients publication-title: Metabolism doi: 10.1016/j.metabol.2007.05.010 – volume: 29 start-page: 788 issue: 6 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib35 article-title: Elevated serum homocysteine levels were not correlated with serum uric acid levels, but with decreased renal function in gouty patients publication-title: J. Korean Med. Sci. doi: 10.3346/jkms.2014.29.6.788 – volume: 354 start-page: 1567 issue: 15 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib25 article-title: Homocysteine lowering with folic acid and B vitamins in vascular disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa060900 – volume: 21 start-page: 106 issue: 1 year: 2006 ident: 10.1016/j.atherosclerosis.2016.03.031_bib49 article-title: Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease publication-title: Indian J. Clin. Biochem. doi: 10.1007/BF02913076 – volume: 58 start-page: 1025 issue: 10 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.031_bib33 article-title: Homocysteine and reclassification of cardiovascular disease risk publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2011.05.028 – volume: 289 start-page: H2649 issue: 6 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib5 article-title: Mechanisms of homocysteine-induced oxidative stress publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00548.2005 – volume: 373 start-page: 1765 issue: 9677 year: 2009 ident: 10.1016/j.atherosclerosis.2016.03.031_bib38 article-title: Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials publication-title: Lancet doi: 10.1016/S0140-6736(09)60697-8 – volume: 34 start-page: 97 issue: 2 year: 2001 ident: 10.1016/j.atherosclerosis.2016.03.031_bib14 article-title: Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction publication-title: Clin. Biochem. doi: 10.1016/S0009-9120(01)00187-4 – volume: 10 year: 2011 ident: 10.1016/j.atherosclerosis.2016.03.031_bib17 article-title: Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects publication-title: Lipids Health Dis. doi: 10.1186/1476-511X-10-137 – volume: 36 start-page: 2404 issue: 11 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib28 article-title: Vitamin intervention for stroke prevention trial: an efficacy analysis publication-title: Stroke doi: 10.1161/01.STR.0000185929.38534.f3 – volume: 40 start-page: 1209 issue: 16–17 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.031_bib39 article-title: Plasma creatinine as a determinant of plasma total homocysteine concentrations in the hordaland homocysteine study: use of statistical modeling to determine reference limits publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2007.07.014 – volume: 138 start-page: 2070 issue: 11 year: 2008 ident: 10.1016/j.atherosclerosis.2016.03.031_bib18 article-title: The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects publication-title: J. Nutr. doi: 10.3945/jn.108.090704 – volume: 27 start-page: 8 issue: 1 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.031_bib4 article-title: Homocysteinylation of metallothionein impairs intracellular redox homeostasis: the enemy within! publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.0000254151.00086.26 – volume: 6 start-page: 779 issue: 9 year: 2013 ident: 10.1016/j.atherosclerosis.2016.03.031_bib34 article-title: Relationship of serum homocysteine level with nutritional status and HbA1c level in elderly inpatients publication-title: Int. J. Clin. Exp. Med. – volume: 19 start-page: 42 issue: 1 year: 2005 ident: 10.1016/j.atherosclerosis.2016.03.031_bib16 article-title: Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 publication-title: J. Diabetes Complicat. doi: 10.1016/j.jdiacomp.2003.12.003 – volume: 6 start-page: 830 issue: 9 year: 2007 ident: 10.1016/j.atherosclerosis.2016.03.031_bib30 article-title: Homocysteine-lowering therapy: a role in stroke prevention? publication-title: Lancet Neurol. doi: 10.1016/S1474-4422(07)70219-3 – volume: 11 issue: 1 year: 2014 ident: 10.1016/j.atherosclerosis.2016.03.031_bib8 article-title: Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes publication-title: Nutr. Metab. Lond. – volume: 14 start-page: 229 issue: 3 year: 2004 ident: 10.1016/j.atherosclerosis.2016.03.031_bib48 article-title: Distribution of total serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: the third national health and nutrition examination survey publication-title: Ann. Epidemiol. doi: 10.1016/S1047-2797(03)00242-4 |
SSID | ssj0004718 |
Score | 2.2641525 |
Snippet | Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear. While reducing serum total... Abstract Background and aims Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, but the mechanism for this risk remains unclear.... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 59 |
SubjectTerms | Aged Atherosclerosis Atherosclerosis - blood Blood Urea Nitrogen Cardiovascular Creatinine - blood Databases, Factual Female Glycated Hemoglobin A - metabolism Glycemic status Homocysteine Homocysteine - blood Humans Insulin - blood Kidney - physiology Kidney function Lipid Lipids - blood Lipoprotein Lipoproteins - blood Male Middle Aged |
Title | Serum homocysteine is not independently associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-21) study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S002191501630106X https://www.clinicalkey.es/playcontent/1-s2.0-S002191501630106X https://dx.doi.org/10.1016/j.atherosclerosis.2016.03.031 https://www.ncbi.nlm.nih.gov/pubmed/27065242 https://www.proquest.com/docview/1791321806 |
Volume | 249 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB6SDYReSt_dtglTaKE9uLH8kO0QSkPSsG03OTVhb0KWJeqysZfYe8il1_7tjGx5Qx-BlIIxWKAHmtGnT9Y8AF4xnQU6jxIvD5nyokISDurEeLmMY6myRKedU9jxCZ-cRp9n8WwNDgZfGGtW6bC_x_QOrV3JjpvNnUVZWh9fWm3EZ4hR2IPNbB02gjDj8Qg29j99mZxcu0cmrAdka41AFTbh9bWZV8ez6oZapXdpA3gz3oU9DdlNW9VNVLTbko7uwV3HJXG_H-59WNPVA9g8drflD-EnAcHyHL_V57WyAZupEMsGq7rFcpX9tp1fonQy0gXa_7IoK-wHTNpVKpyXi7JAl917F0mz8ExfXOLUWpHjoWyl3QuxNmgzYRcNvjmbHk69gL3FLnrtIzg9-vj1YOK5xAuein3eepJnKtJhnCmaM5MZIn0qldr4Mk5MkCo6xRidRqlfcMVSLWWaR8bYC1OekFL44WMYVXWln1qXcC5VGIWRUUmUKz-TgUxVIVlB5IGOimPYG-ZYKBeV3CbHmIvB_Oy7-E1EwopI-CE9bAx8VX3Rh-e4bcX3g0DF4INKqCloI7ltA8nfGtCNw4BGMNEEwhd_6OkYPqxq_qLq_9L5y0EHBcGBveORla6X1GmSsZBom8_H8KRXztXEBFZCRMme_f8AnsMd-9XbzL2AUXux1FvEztp8G9bf_WDbbg1eAZyGPv0 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLZKkQoXxM6wPiSQ4JA2TpwNIQRqqQbI9NRWc7McxxZB02TUZA69cOVv817iTMVSqQgpyiGJF_k9f_4cv4WxF9xkgSlE4hUh154oFeKgSaxXqChSOktM2juFzQ7i6ZH4PI_mG2x39IUhs0qH_QOm92jtnuy40dxZVhX5-OJsQz6DjII2NvMr7KqIwoTs-ra_n9t5EPoOdh7co8-32MtzI6-eZTUt1on3isJ387gPehryixaqi4hovyDt32Q3HJOED0Nnb7ENU99mWzN3Vn6H_UAYWJ3A1-ak0RSuGR9C1ULddFCtc992izNQTkKmBPorC6qGocOoW5WGRbWsSnC5vd8A6hUcm9MzyMmGHPZUp2glhMYC5cEuW3h1nO_lXsBfQx-79i472v94uDv1XNoFT0d-3HkqzrQwYZRpHDObWaR8OlXG-ipKbJBq3MNYk4rUL2PNU6NUWghr6bg0TlAl_PAe26yb2jwgh_BY6VCEwupEFNrPVKBSXSpeInXAjeKEvR3HWGoXk5xSYyzkaHz2Tf4mIkkikn6IF5-weF18OQTnuGzBd6NA5eiBipgpcRm5bAXJ3yowrUOAVnLZBtKXf2jphL1fl_xF0f-l8eejDkoEAzrhUbVpVthokvEQSZsfT9j9QTnXAxOQhJCQPfz_Djxj16aHs1zmnw6-PGLX6c1gPfeYbXanK_MEeVpXPO3n4U9hxj_I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+homocysteine+is+not+independently+associated+with+an+atherogenic+lipid+profile%3A+The+Very+Large+Database+of+Lipids+%28VLDL-21%29+study&rft.jtitle=Atherosclerosis&rft.au=Lupton%2C+Joshua+R.&rft.au=Quispe%2C+Renato&rft.au=Kulkarni%2C+Krishnaji&rft.au=Martin%2C+Seth+S.&rft.date=2016-06-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0021-9150&rft.eissn=1879-1484&rft.volume=249&rft.spage=59&rft.epage=64&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2016.03.031&rft.externalDocID=S002191501630106X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219150%2FS0021915016X00044%2Fcov150h.gif |